Endocrinology Roundup: Stem Cell Infusion Slashes Fractures, Testosterone Debate and Links Between Bone Density and Cognition

A small stem cell trial showed a 94% drop in fragility fractures; new GLP-1 and dual-agonist data shift the obesity landscape; regulators, courts, and insurers weigh in on testosterone and GLP-1s.








